Prat M - Search Results

1

Expression of functional tyrosine kinases on immortalized Kaposi's sarcoma cells.

Montaldo F, Maffé A, Morini M, Noonan D, Giordano S, Albini A, Prat M. Montaldo F, et al. Among authors: prat m. J Cell Physiol. 2000 Aug;184(2):246-54. doi: 10.1002/1097-4652(200008)184:2<246::AID-JCP13>3.0.CO;2-O. J Cell Physiol. 2000. PMID: 10867650

2

C-terminal truncated forms of Met, the hepatocyte growth factor receptor.

Prat M, Crepaldi T, Gandino L, Giordano S, Longati P, Comoglio P. Prat M, et al. Mol Cell Biol. 1991 Dec;11(12):5954-62. doi: 10.1128/mcb.11.12.5954-5962.1991. Mol Cell Biol. 1991. PMID: 1944272 Free PMC article.

3

Generation of a truncated hepatocyte growth factor receptor in the endoplasmic reticulum.

Crepaldi T, Prat M, Giordano S, Medico E, Comoglio PM. Crepaldi T, et al. Among authors: prat m. J Biol Chem. 1994 Jan 21;269(3):1750-5. J Biol Chem. 1994. PMID: 8294424 Free article.

4

Over-expression of hepatocyte growth factor in human Kaposi's sarcoma.

Maier JA, Mariotti M, Albini A, Comi P, Prat M, Comogilio PM, Soria MR. Maier JA, et al. Among authors: prat m. Int J Cancer. 1996 Jan 17;65(2):168-72. doi: 10.1002/(SICI)1097-0215(19960117)65:2<168::AID-IJC7>3.0.CO;2-X. Int J Cancer. 1996. PMID: 8567112

5

The tyrosine kinase receptor met and its ligand HGF are co-expressed and functionally active in HHV-8 positive primary effusion lymphoma.

Capello D, Gaidano G, Gallicchio M, Gloghini A, Medico E, Vivenza D, Buonaiuto D, Fassone L, Avanzi GC, Saglio G, Prat M, Carbone A. Capello D, et al. Among authors: prat m. Leukemia. 2000 Feb;14(2):285-91. doi: 10.1038/sj.leu.2401666. Leukemia. 2000. PMID: 10673746

6

Phenotypic alterations in Kaposi's sarcoma cells by antisense reduction of perlecan.

Marchisone C, Del Grosso F, Masiello L, Prat M, Santi L, Noonan DM. Marchisone C, et al. Among authors: prat m. Pathol Oncol Res. 2000;6(1):10-7. doi: 10.1007/BF03032652. Pathol Oncol Res. 2000. PMID: 10749582 Free article.

7

Agonist Met antibodies define the signalling threshold required for a full mitogenic and invasive program of Kaposi's Sarcoma cells.

Bardelli C, Sala M, Cavallazzi U, Prat M. Bardelli C, et al. Among authors: prat m. Biochem Biophys Res Commun. 2005 Sep 9;334(4):1172-9. doi: 10.1016/j.bbrc.2005.07.020. Biochem Biophys Res Commun. 2005. PMID: 16039997

8

Cell delivery of Met docking site peptides inhibit angiogenesis and vascular tumor growth.

Cantelmo AR, Cammarota R, Noonan DM, Focaccetti C, Comoglio PM, Prat M, Albini A. Cantelmo AR, et al. Among authors: prat m. Oncogene. 2010 Sep 23;29(38):5286-98. doi: 10.1038/onc.2010.267. Epub 2010 Jul 5. Oncogene. 2010. PMID: 20603611 Free PMC article.

9

Diacylglycerol kinases are essential for hepatocyte growth factor-dependent proliferation and motility of Kaposi's sarcoma cells.

Baldanzi G, Pietronave S, Locarno D, Merlin S, Porporato P, Chianale F, Filigheddu N, Cantelmo AR, Albini A, Graziani A, Prat M. Baldanzi G, et al. Among authors: prat m. Cancer Sci. 2011 Jul;102(7):1329-36. doi: 10.1111/j.1349-7006.2011.01953.x. Epub 2011 May 18. Cancer Sci. 2011. PMID: 21477072 Free article.

10

Tyrosine kinase and control of cell proliferation.

Comoglio PM, Di Renzo MF, Gaudino G, Ponzetto C, Prat M. Comoglio PM, et al. Among authors: prat m. Am Rev Respir Dis. 1990 Dec;142(6 Pt 2):S16-9. doi: 10.1164/ajrccm/142.6_Pt_2.S16. Am Rev Respir Dis. 1990. PMID: 1701290 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

320 results

Search Page

Filters